Natera, Inc. (NTRA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$200.99
-1.66%
Mkt Cap $29.11B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $604.04M | $665.50M | +10.18% | -$0.51 | $0.35 | +168.35% | — | — |
| Q4 2025 Nov 6, 2025 | $513.45M | $592.18M | +15.33% | -$0.39 | -$0.64 | -65.94% | — | — |
| Q3 2025 Aug 7, 2025 | $476.26M | $546.60M | +14.77% | -$0.62 | -$0.74 | -20.24% | — | — |
| Q2 2025 May 8, 2025 | $446.23M | $501.83M | +12.46% | -$0.64 | -$0.50 | +21.93% | — | — |
| Q1 2025 Feb 27, 2025 | $435.64M | $476.06M | +9.28% | -$0.38 | -$0.41 | -7.57% | — | — |
| Q4 2024 Nov 12, 2024 | $361.43M | $439.76M | +21.67% | -$0.57 | -$0.26 | +54.39% | — | — |
| Q3 2024 Aug 8, 2024 | $343.00M | $413.35M | +20.51% | -$0.69 | -$0.30 | +56.52% | — | — |
| Q2 2024 May 9, 2024 | $316.31M | $367.74M | +16.26% | -$0.71 | -$0.56 | +21.13% | — | — |
| Q1 2024 Feb 28, 2024 | $300.00M | $311.11M | +3.70% | -$0.73 | -$0.64 | +12.33% | — | — |
| Q4 2023 Nov 8, 2023 | $259.15M | $268.31M | +3.53% | -$0.96 | -$0.95 | +1.04% | — | — |
| Q3 2023 Aug 3, 2023 | $255.75M | $261.40M | +2.21% | -$1.09 | -$0.97 | +11.01% | — | — |
| Q2 2023 May 9, 2023 | $227.67M | $241.76M | +6.19% | -$1.15 | -$1.23 | -6.96% | — | — |
| Q1 2023 Feb 28, 2023 | $215.57M | $217.25M | +0.78% | -$1.42 | -$1.37 | +3.52% | — | — |
| Q4 2022 Nov 8, 2022 | $206.66M | $210.64M | +1.93% | -$1.44 | -$1.25 | +13.19% | — | — |
| Q3 2022 Aug 4, 2022 | $193.67M | $198.20M | +2.34% | -$1.50 | -$1.50 | +0.00% | — | — |
| Q2 2022 May 5, 2022 | $198.07M | $194.13M | -1.99% | -$1.48 | -$1.45 | +2.03% | — | — |
| Q1 2022 Feb 24, 2022 | $168.94M | $173.03M | +2.42% | -$1.31 | -$1.48 | -12.98% | — | — |
| Q4 2021 Nov 4, 2021 | $150.81M | $158.12M | +4.84% | -$1.27 | -$1.63 | -28.35% | — | — |
| Q3 2021 Aug 5, 2021 | $129.71M | $142.03M | +9.50% | -$1.12 | -$1.32 | -17.86% | — | — |
| Q2 2021 May 6, 2021 | $194.13M | $152.32M | -21.54% | -$1.02 | -$0.74 | +27.45% | — | — |